BioNTech starts human trial to test malaria vaccine

BioNTech starts human trial to test malaria vaccine BioNTech on Friday initiated an early-stage study to evaluate its experimental malaria vaccine in humans, the German drugmaker said. Reuters Reuters

...

The effort is one of several focused on addressing the mosquito-borne disease that kills over 600,000 each year, most of them children in Africa. The complicated structure and lifecycle of the malaria parasite has long stymied efforts to develop vaccines.

...